Circulating L-selectin concentrations in children with recent-onset IDDM

Area of Science:

• Immunology
• Endocrinology
• Pediatrics

Background:

• Conflicting reports exist regarding serum concentrations of soluble L-selectin (sCD62L) in recent-onset type 1 diabetes mellitus (IDDM).
• sCD62L is a marker of leukocyte activation, potentially relevant in inflammatory conditions like diabetes.
• Age significantly influences sCD62L levels, complicating interpretation in pediatric populations.

Purpose of the Study:

• To investigate and clarify altered serum sCD62L concentrations in children and adolescents with recent-onset IDDM.
• To assess the relationship between sCD62L levels, IDDM status, and age.
• To determine the clinical utility of sCD62L measurements in pediatric IDDM.

Main Methods:

• Serum sCD62L concentrations were measured in 89 children and adolescents with IDDM (categorized by disease duration) and 124 age-matched controls.
• Participants included recent-onset IDDM, those within the first year of insulin treatment, and those with long-standing IDDM.
• Multivariate analysis was employed to assess the association between sCD62L, age, and IDDM status.

Main Results:

• Younger children (< 14 years) exhibited significantly higher sCD62L concentrations compared to adolescents and adults, irrespective of diabetes status.
• A strong inverse association was confirmed between chronological age and sCD62L levels (p < 0.001).
• Recent-onset IDDM patients showed slightly elevated sCD62L compared to insulin-treated IDDM patients and non-diabetic controls (p = 0.028), a finding masked by age effects.

Conclusions:

• While a minor increase in systemic sCD62L in recent-onset IDDM suggests leukocyte activation, it is significantly confounded by age.
• The strong inverse correlation between age and sCD62L in pediatric populations limits its diagnostic value.
• Serum sCD62L measurement holds limited clinical value for researchers and clinicians managing pediatric IDDM.